MADISON HEIGHTS, MI--(Marketwired - May 12, 2014) - Creative Edge Nutrition, Inc. (OTC Pink: FITX) (
"We purchased the site with the intentions of operating a research and development facility with respect to strain genetics, new grow techniques and bio-medical research," commented Bill Chaaban, President & CEO. "It has been our intention to not only grow and sell medical marijuana, but to be leaders in the forefront of medical marijuana research; In particular, to further identify treatment modalities for specific disease states based on strain selection. We intend to develop and own the intellectual property."
Dr. Sam Alawieh, Dr. David Felten and their medical advisory board will be instrumental in this research.
For a video of the property, please view
http://windsor.ctvnews.ca/video?clipId=316839
About Creative Edge Nutrition, Inc.
Creative Edge Nutrition is a holding company and a Nutritional Supplement Company focused on developing innovative, high quality supplements. The company offers a broad spectrum of capsules, tablets, and powders, as well as science based products in the principal categories of weight management, nutrition challenges, energy and fitness. The Company manufactures under strict GMP guidelines at GMP Certified and/or FDA registered facilities. http://www.cenergynutrition.com and https://www.facebook.com/CenergyNutrition
About CEN Biotech
CEN Biotech, Inc. was established in 2013 as a partially owned subsidiary of Creative Edge Nutrition (OTC Pink: FITX) (
http://www.cenbiotechinc.com
Contact:
FOR INVESTOR RELATIONS
William Swalm
(212) 584-4342
Info@cenergynutrition.com